In Vitro Diagnostics (IVD) Quality Control Market Report Forecasts Impressive Growth by 2022 - Scalar Market Research

Chicago, IL -- (SBWIRE) -- 09/15/2017 -- There is growth in the global market for IVD owing to various factors including the increasing number of accredited clinical laboratories and growing adoption of third-party quality controls to ensure unbiased test results. Moreover, the increasing use of multi-analyte controls and increasing focus of key players on emerging countries are creating new growth opportunities for this market. However, uncertainty in reimbursement and lack of regulations are restraining the growth of the market.

Download Free Sample:

The report on the global In vitro diagnostics (IVD) quality control market uses the top-down and bottom-up approaches to define, analyze, and describe the market trends for the next five years. The report also tracks the emerging applications, innovative technologies, and mergers & acquisitions. It also focuses on the growth drivers and restraints for the key market players during the forecast period.

Enquiry Beofre Buying:


1. The global market for In Vitro Diagnostics (IVD) quality control is fueled by various factors such as increasing no. of clinical laboratories, rising adoption of quality control of third party and escalating market demand for support of external quality assessment.

2. However, extra costing of IVD and constraint budget in laboratories and hospitals as well as unfavorable scenario of IVD test reimbursement are few hindering factors of global the In Vitro Diagnostics (IVD) quality control market. Also, one major opportunity occurring in the global In Vitro Diagnostics (IVD) quality control market is the growing market demand for multi-analyte controls.

3. On the other hand, strict process of product approval and lack of regulations that are mandatory for accreditation clinical laboratory in various emerging economies are the major challenges in the global market for In Vitro Diagnostics (IVD) quality control.

Regionally, the global In Vitro Diagnostics (IVD) quality control market is classified into North America, Europe, Asia-Pacific, and the Rest of the World. Among these regions, North America is anticipated to be the market leader in the global market for In Vitro Diagnostics (IVD) quality control in the years to come. Several economies such as Canada and the US in this region are observing growing market demand for In Vitro Diagnostics (IVD) quality control. This market is Asia-Pacific and European regions is anticipated to observe high growth.

key market players

Key players in the in vitro diagnostics (IVD) quality control market include:

1. Roche Diagnostics
2. Abbott Laboratories Inc.
3. Thermo Fisher Scientific Inc.
4. Helena Laboratories
5. Seracare Life Sciences, Inc.
6. Sero as
7. Randox Laboratories Ltd.
8. Siemens AG
9. Technopath Clinical Diagnostics
10. Ortho Clinical Diagnostics, Inc.
11. Sun Diagnostics, LLC

Browse Report:

About Scalar Market Research
Scalar Market Research Inc. aspires to assist organizations from around the world to achieve their business goal with premium market research reports and consulting services. Our real-time industry tracking with the help of advanced analytics offers a crystal clear view of all the activities in niche markets. Our team, with thorough global understanding, works relentlessly to gather the necessary market insights, including customer analysis, competitions and global forecast.

Find out more about our services at:

Source :

Related Posts